 Alia Al-Tayyib
Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance Abuse, Intravenous | 9 | 2020 | 106 | 2.590 |
Why?
| | Homosexuality, Male | 7 | 2022 | 171 | 1.520 |
Why?
| | Opioid-Related Disorders | 7 | 2022 | 502 | 1.510 |
Why?
| | Hepatitis C | 6 | 2023 | 234 | 1.050 |
Why?
| | Prescription Drug Misuse | 2 | 2017 | 42 | 0.980 |
Why?
| | HIV Infections | 17 | 2024 | 2696 | 0.970 |
Why?
| | Gonorrhea | 4 | 2012 | 55 | 0.950 |
Why?
| | Sexual Behavior | 10 | 2022 | 453 | 0.940 |
Why?
| | Heroin Dependence | 2 | 2017 | 31 | 0.890 |
Why?
| | Amphetamine-Related Disorders | 3 | 2024 | 36 | 0.810 |
Why?
| | Emergency Service, Hospital | 12 | 2024 | 1977 | 0.740 |
Why?
| | Chlamydia Infections | 4 | 2012 | 71 | 0.730 |
Why?
| | Methamphetamine | 4 | 2024 | 57 | 0.720 |
Why?
| | Unsafe Sex | 3 | 2017 | 55 | 0.680 |
Why?
| | Internet | 2 | 2017 | 616 | 0.630 |
Why?
| | Drug Overdose | 3 | 2020 | 330 | 0.610 |
Why?
| | Sexual Partners | 4 | 2018 | 179 | 0.600 |
Why?
| | Substance-Related Disorders | 5 | 2020 | 1019 | 0.580 |
Why?
| | Buprenorphine | 1 | 2021 | 169 | 0.580 |
Why?
| | Analgesics, Opioid | 5 | 2022 | 914 | 0.560 |
Why?
| | Mass Screening | 10 | 2024 | 1121 | 0.560 |
Why?
| | Prescription Drugs | 1 | 2016 | 116 | 0.470 |
Why?
| | Mobile Applications | 1 | 2017 | 158 | 0.450 |
Why?
| | Colorado | 12 | 2024 | 4443 | 0.450 |
Why?
| | Homeless Youth | 1 | 2013 | 18 | 0.440 |
Why?
| | Adult | 34 | 2024 | 35361 | 0.420 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 258 | 0.410 |
Why?
| | Primary Prevention | 1 | 2014 | 191 | 0.400 |
Why?
| | Public Health | 1 | 2016 | 493 | 0.380 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2020 | 1264 | 0.370 |
Why?
| | Male | 38 | 2024 | 63146 | 0.360 |
Why?
| | Social Stigma | 2 | 2022 | 112 | 0.350 |
Why?
| | Risk-Taking | 6 | 2020 | 344 | 0.340 |
Why?
| | Methadone | 1 | 2011 | 92 | 0.330 |
Why?
| | Comorbidity | 3 | 2021 | 1542 | 0.330 |
Why?
| | Young Adult | 16 | 2024 | 12286 | 0.320 |
Why?
| | Heterosexuality | 3 | 2018 | 30 | 0.320 |
Why?
| | Attitude | 1 | 2011 | 247 | 0.320 |
Why?
| | Hepacivirus | 4 | 2023 | 235 | 0.310 |
Why?
| | Opiate Substitution Treatment | 2 | 2021 | 140 | 0.310 |
Why?
| | Telephone | 2 | 2009 | 167 | 0.310 |
Why?
| | Safety-net Providers | 2 | 2020 | 108 | 0.310 |
Why?
| | Prevalence | 6 | 2019 | 2540 | 0.300 |
Why?
| | Heroin | 2 | 2020 | 30 | 0.300 |
Why?
| | Adolescent | 18 | 2021 | 20197 | 0.290 |
Why?
| | Surveys and Questionnaires | 4 | 2017 | 5355 | 0.290 |
Why?
| | Middle Aged | 21 | 2024 | 30977 | 0.290 |
Why?
| | Health Services Accessibility | 3 | 2022 | 894 | 0.280 |
Why?
| | Humans | 44 | 2024 | 128896 | 0.280 |
Why?
| | Female | 32 | 2024 | 68162 | 0.270 |
Why?
| | Self Disclosure | 2 | 2009 | 61 | 0.270 |
Why?
| | Psychoses, Substance-Induced | 1 | 2024 | 14 | 0.230 |
Why?
| | United States | 16 | 2024 | 13975 | 0.220 |
Why?
| | Cities | 3 | 2020 | 101 | 0.220 |
Why?
| | Behavioral Risk Factor Surveillance System | 4 | 2017 | 47 | 0.210 |
Why?
| | Socioeconomic Factors | 6 | 2020 | 1192 | 0.210 |
Why?
| | Interviews as Topic | 3 | 2024 | 696 | 0.200 |
Why?
| | Baltimore | 3 | 2008 | 45 | 0.200 |
Why?
| | Cost-Benefit Analysis | 2 | 2024 | 615 | 0.200 |
Why?
| | Health Surveys | 2 | 2009 | 485 | 0.190 |
Why?
| | Insurance, Health | 2 | 2015 | 269 | 0.190 |
Why?
| | Family Planning Services | 1 | 2022 | 81 | 0.190 |
Why?
| | Consensus | 1 | 2024 | 644 | 0.180 |
Why?
| | Needle Sharing | 1 | 2020 | 10 | 0.180 |
Why?
| | Needle-Exchange Programs | 1 | 2020 | 7 | 0.180 |
Why?
| | Educational Status | 1 | 2002 | 458 | 0.170 |
Why?
| | Risk | 2 | 2016 | 866 | 0.170 |
Why?
| | Allied Health Personnel | 1 | 2020 | 42 | 0.170 |
Why?
| | Drug Users | 1 | 2020 | 44 | 0.160 |
Why?
| | Sexual and Gender Minorities | 1 | 2022 | 157 | 0.160 |
Why?
| | Washington | 2 | 2020 | 149 | 0.160 |
Why?
| | Neisseria gonorrhoeae | 2 | 2008 | 22 | 0.150 |
Why?
| | Chlamydia trachomatis | 2 | 2008 | 44 | 0.150 |
Why?
| | HIV | 3 | 2019 | 223 | 0.150 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2020 | 201 | 0.140 |
Why?
| | Qualitative Research | 1 | 2024 | 1192 | 0.140 |
Why?
| | Patient Acceptance of Health Care | 2 | 2012 | 764 | 0.130 |
Why?
| | Condoms | 2 | 2014 | 102 | 0.130 |
Why?
| | Patient Participation | 1 | 2019 | 402 | 0.120 |
Why?
| | Emergency Medical Services | 2 | 2020 | 562 | 0.120 |
Why?
| | Machine Learning | 1 | 2020 | 417 | 0.120 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 101 | 0.120 |
Why?
| | Reproductive Health | 1 | 2015 | 79 | 0.120 |
Why?
| | Public Health Surveillance | 1 | 2015 | 68 | 0.120 |
Why?
| | Adolescent Behavior | 1 | 2020 | 498 | 0.120 |
Why?
| | Interpersonal Relations | 1 | 2018 | 387 | 0.120 |
Why?
| | Health Care Reform | 1 | 2015 | 100 | 0.120 |
Why?
| | Insurance Coverage | 2 | 2015 | 220 | 0.110 |
Why?
| | Sexually Transmitted Diseases | 1 | 2015 | 146 | 0.110 |
Why?
| | Contact Tracing | 1 | 2012 | 20 | 0.100 |
Why?
| | AIDS Serodiagnosis | 1 | 2012 | 27 | 0.100 |
Why?
| | Hepatitis C Antibodies | 1 | 2011 | 9 | 0.100 |
Why?
| | Sex Factors | 1 | 2017 | 1947 | 0.100 |
Why?
| | Clinical Laboratory Techniques | 1 | 2011 | 86 | 0.090 |
Why?
| | Health Promotion | 1 | 2017 | 712 | 0.090 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1504 | 0.090 |
Why?
| | Urban Population | 2 | 2012 | 436 | 0.080 |
Why?
| | ROC Curve | 1 | 2011 | 500 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2013 | 387 | 0.080 |
Why?
| | Prospective Studies | 5 | 2023 | 7060 | 0.080 |
Why?
| | Cross-Sectional Studies | 2 | 2011 | 5032 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2023 | 10239 | 0.070 |
Why?
| | Risk Assessment | 1 | 2015 | 3286 | 0.060 |
Why?
| | Alcoholism | 2 | 2020 | 759 | 0.060 |
Why?
| | Bias | 1 | 2005 | 196 | 0.060 |
Why?
| | Age Factors | 2 | 2009 | 3133 | 0.060 |
Why?
| | Risk Factors | 3 | 2019 | 9792 | 0.050 |
Why?
| | Logistic Models | 1 | 2008 | 1963 | 0.050 |
Why?
| | Central Nervous System Stimulants | 1 | 2024 | 153 | 0.050 |
Why?
| | Data Collection | 1 | 2005 | 652 | 0.050 |
Why?
| | Sex Education | 1 | 2022 | 28 | 0.050 |
Why?
| | Pregnancy, Unplanned | 1 | 2022 | 37 | 0.050 |
Why?
| | Intention to Treat Analysis | 1 | 2021 | 72 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2008 | 3334 | 0.050 |
Why?
| | Contraception | 1 | 2022 | 142 | 0.040 |
Why?
| | Oregon | 1 | 2020 | 68 | 0.040 |
Why?
| | Algorithms | 1 | 2008 | 1626 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 211 | 0.040 |
Why?
| | Aged | 2 | 2016 | 22035 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2024 | 727 | 0.040 |
Why?
| | Odds Ratio | 1 | 2021 | 1019 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2020 | 253 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 456 | 0.040 |
Why?
| | Gender Identity | 1 | 2018 | 114 | 0.040 |
Why?
| | Family | 1 | 2022 | 650 | 0.040 |
Why?
| | Self Efficacy | 1 | 2020 | 377 | 0.030 |
Why?
| | Minority Groups | 1 | 2018 | 240 | 0.030 |
Why?
| | Medicaid | 1 | 2020 | 445 | 0.030 |
Why?
| | Health Status | 1 | 2020 | 750 | 0.030 |
Why?
| | Censuses | 1 | 2015 | 27 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 896 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 966 | 0.030 |
Why?
| | Cognition | 1 | 2002 | 1093 | 0.030 |
Why?
| | Cohort Studies | 2 | 2015 | 5394 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2019 | 708 | 0.030 |
Why?
| | Phylogeny | 1 | 2017 | 843 | 0.030 |
Why?
| | Research Design | 1 | 2019 | 1038 | 0.030 |
Why?
| | Medical Assistance | 1 | 2012 | 12 | 0.020 |
Why?
| | Hospitals, Urban | 1 | 2012 | 133 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2008 | 14546 | 0.020 |
Why?
| | Guidelines as Topic | 1 | 2012 | 259 | 0.020 |
Why?
| | Hospitalization | 1 | 2020 | 2080 | 0.020 |
Why?
| | Comprehension | 1 | 2012 | 167 | 0.020 |
Why?
| | Saliva | 1 | 2011 | 204 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 6247 | 0.020 |
Why?
| | Child | 2 | 2020 | 20824 | 0.020 |
Why?
| | Triage | 1 | 2012 | 211 | 0.020 |
Why?
| | Hepatitis C, Chronic | 1 | 2011 | 154 | 0.020 |
Why?
| | Computers | 1 | 2009 | 64 | 0.020 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2009 | 67 | 0.020 |
Why?
| | Contraception Behavior | 1 | 2009 | 91 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 428 | 0.020 |
Why?
| | User-Computer Interface | 1 | 2009 | 147 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2012 | 1002 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1840 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3042 | 0.010 |
Why?
|
|
Al-Tayyib's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|